Asahikawa Medical University
- Academic, tech transfer
Asahikawa Medical University is engaged in a number of research projects to address the clinical needs in the real world. At Bio2025, we will focus on our original drug candidates, Therapeutic Agent for IBD, Anti-Cancer Agent and Therapeutic Agent for PD.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}